ArticleBMC endocrine disorders2021

Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification.

Sachiko Ohde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.